Some blood pressure medications are not the best choice anymore, either due to their side effects or limited effectiveness.

Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular ...

The Food and Drug Administration (FDA) has issued a Complete Response Letter to Milestone Pharmaceuticals regarding the New Drug Application (NDA) for ...

Pharmaceutical Administration Bureau has approved IASO Biotherapeutics’ new drug application (NDA) for equecabtagene ...

Police have appealed for information about a suspect after a car crash and drugs seizure in Co Tyrone. Officers on a mobile ...

A "real plan" is needed to deal with the problems caused by a country that is "at the minute, absolutely awash with cocaine", ...

Learn more about whether Alvotech or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades ...

Proposed US tariffs on pharmaceutical exports will damage the economic prospects of US companies in Ireland, the Irish ...

CRL focused on CMC; no clinical issues relating to etripamil raised $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024 MONTREAL and CHARLOTTE, N.C., March 28, 2025 ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The researchers found that several types of blood pressure medications—especially ACE inhibitors, beta-blockers, ...

Three Romanian nationals will be sentenced next month on charges related to cash trapping devices placed in 43 ATMs across ...